All In MedTech

Device Trial Radar · NCT03918460

ANEUFIX for Endoleak Type II Repair

Treatment of Type II Endoleak With ANEUFIX: Assessment of Safety, Performance and Clinical Benefit.

Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

May 13, 2020

Primary completion

Sep 24, 2026

Study completion Mar 24, 2028

Sponsor

Lead sponsor
TripleMed B.V.Not on our public-company list
Sponsor type
Industry
Collaborators
Trium Clinical Consulting
First posted
Apr 17, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is non-randomized, multicenter international safety, performance and clinical benefit outcome assessment of ANEUFIX to treat patients with isolated type II endoleak in the presence of a growing AAA-sac following an EVAR procedure more than 6 months ago.

Conditions

  • Abdominal Aortic Aneurysm
  • Endoleak

Interventions

  • ANEUFIXDevice

    ANEUFIX is administered through translumbar injection into the AAA using imaging techniques to guide the place of injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical success rateTime frame: 24 hours

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • Imelda

    Bonheiden, Belgium

  • ZOL

    Genk, Belgium

  • UZ Leuven

    Leuven, Belgium

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.